# James Wang

> James Wang is a seed investor at Lioness (Berkeley) backing Health Care and Software. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Lioness](https://shizune.co/investors/profile/lioness)
- Location: Berkeley, United States
- Total investments: 3
- Last investment: Aug 2022
- Lead investor: 67%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/jwang10/
- X (Twitter): https://twitter.com/avantos
- Website: https://x.com/avantos

James Wang is a co-founder of Lioness, currently serving as CTO and COO. His specialities management, software development, and statistical analysis and learning (AI/machine learning). Previously, he spearheaded the launch announcement and branding for Google X's Makani project pilot in Hawaii, led a team of analysts at BridgewaterAssociates, and co-founded and managed a consulting group specializing in microfinance in the developing world.James holds an MBA from UC Berkeley where he was a Jack Larson Fellow in Entrepreneurship, a BA with Honors from Dartmouth, and is an MS Computer Science candidate at Georgia Tech. He also holds a Data Science Specialization from the John Hopkins Bloomberg School of Public Health and completed the course track for a PhD Designated Emphasis in Computational Sciences and Engineering at Berkeley.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 100% |
| Software | 2 | 67% |
| Biotechnology | 2 | 67% |
| Medical Device | 2 | 67% |
| Medical | 1 | 33% |

7 industries tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Canada | 1 | 33% |
| Argentina | 1 | 33% |
| United States | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| OncoPrecision | We're developing personalized assays to determine the most suitable medication for cancer therapy at the patient level. Through our proprietary Drug Activity and Resistance Test, oncologists will be able to make data-driven decisions regarding cancer therapy selection based on patient-derived samples. Our goal is to democratize access toPrecision Oncology and improve cancer patients' lives. | $3.3M | Seed | Aug 01, 2022 |  |
| Oncoustics AI | Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Unlike other players in the space, Oncoustics does not do image recognition. Instead, Oncoustics applies AI to raw ultrasound signals from readily available handheldultrasound devices to rapidly differentiate healthy versus diseased tissues. There's a wealth of information in these raw signals and this approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. Initially targeting liver disease, a $30B global diagnostic market, Oncoustics has filed a Breakthrough Device Designation Request with the FDA for the OnX that detects liver fibrosis and the 510K is underway. Several follow-on liver products are in development. Oncoustics also has clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers. | $5M | Seed | Jul 21, 2022 |  |
| C. Light Technologies | C. Light is a neurotech company utilizing advanced machine learning and the most accurate commercially-available eye tracker (by 150X) to assess neurological health, starting with multiple sclerosis. it is a developer of a retinal eye-tracking platform used to improve the monitoring of neurodegenerative diseases. | $4.1M | Seed | Feb 02, 2021 |  |

3 of 3 investments shown.

## Co-investors
- [Band of Angels](https://shizune.co/investors/profile/band-of-angels) — VC Fund, 1 deal together
- [Berkeley SkyDeck Fund](https://shizune.co/investors/profile/berkeley-skydeck-fund) — VC Fund, 1 deal together
- [EGB Capital](https://shizune.co/investors/profile/egb-capital) — VC Fund, 1 deal together
- [Fraser Kearney Capital Corp.](https://shizune.co/investors/profile/fraser-kearney-capital-corp) — VC Fund, 1 deal together
- [Fundacion para el Progreso de la Medicina](https://shizune.co/investors/profile/fundacion-para-el-progreso-de-la-medicina) — VC Fund, 1 deal together
- [GRID EXPONENTIAL](https://shizune.co/investors/profile/grid-exponential) — VC Fund, 1 deal together

## About Lioness

VC Fund · Berkeley, United States

Lioness is a team of designers and engineers building a vibrator that helps you understand, discover, and take control of your own body, paired with an app that allows you to easily visualize what your body is telling you and ask questions to a supportive community. Using advanced biometric sensing and statistical methods, we help you characterizeyour sexuality—how fast you get aroused, how long it generally takes to orgasm, and when sex would feel best—both individually and within the diverse sexual spectrum of the aggregate female population.Finally, as a company with strong female technology, design, and executive leadership, their product is women-centric at its core, from their choices to use the same materials as those used in medical devices to tailoring their device's ergonomics to how women actually hold vibrators. Changing the conversation around female sexuality is hard, but their team is determined to take on the challenge.

5 contacts available at Lioness.

| Name | Title | Profile |
| --- | --- | --- |
| Anna Lee | Co-Founder and Lead Engineer | https://shizune.co/investors/profile/anna-lee-2 |
| Betsy Rohney | Community Manager | https://shizune.co/investors/profile/betsy-rohney |
| James Wang | Co-founder and CTO / COO | https://shizune.co/investors/profile/james-wang-7 |
| Leo Chen | Hardware Lead | https://shizune.co/investors/profile/leo-chen-2 |
| Liz Klinger | Co-founder & CEO | https://shizune.co/investors/profile/liz-klinger |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does James Wang invest in?

James Wang invests primarily in Health Care, Software and Biotechnology startups, most often at Seed stage. Most of the 3 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did James Wang last invest?

The most recent investment recorded for James Wang closed in Aug 2022. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co